32 Supported by research
Sucrose is a disaccharide composed of two joined sugar molecules: glucose and fructose.
"table sugar, which is sucrose, is actually made out of two molecules joined together, which is glucose and fructose." (said at 0:05:05)
Sucrose (table sugar) is a disaccharide carbohydrate composed of two bonded monosaccharide units: glucose and fructose.
Fructose is significantly sweeter than glucose because it binds more effectively to sweet taste receptors.
"fructose is the sweetest naturally occurring sugar we know of, significantly sweeter than glucose itself. When sucrose sits on your tongue, it activates the sweet taste receptors immediately and powerfully, partly because fructose binds to those receptors more effectively than glucose does." (said at 0:05:10)
Fructose is well-established in nutritional and sensory literature as the sweetest naturally occurring sugar/carbohydrate, possessing a relative sweetness significantly higher than glucose (and roughly 1.2 to 1.7 times sweeter than sucrose, whereas glucose has a relative sweetness of approximately 0.7 to 0.8 relative to sucrose). Natural sugars activate the heterodimeric sweet taste receptor (T1R2/T1R3) on taste receptor cells with differing potencies and affinities, underlying the higher perceived sweetness of fructose compared to glucose. Note that when sucrose (table sugar) is tasted, the intact disaccharide directly binds and activates the sweet taste receptor heterodimer without requiring enzymatic hydrolysis into glucose and fructose on the tongue.
- supports: Is fructose the optimal low glycemic index sweetener? (Nestle Nutrition workshop series. Clinical & performance programme 2006) · cited 40x in the literature
"Fructose is a monosaccharide which is abundant in nature. It is the sweetest naturally occurring carbohydrate." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Dietary Fructose and the Metabolic Syndrome. (Nutrients 2019) · cited 301x in the literature
"Consumption of fructose, the sweetest of all naturally occurring carbohydrates, has increased dramatically in the last 40 years and is today commonly used commercially in soft drinks, juice, and baked goods." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Glycation With Fructose: The Bitter Side of Nature's Own Sweetener. (Current diabetes reviews 2020) · cited 14x in the literature
"Fructose is a ketohexose and sweetest among all the natural sugars." (abstract, results, passage verified)
pubmedfull study (doi)
Chronically elevated blood glucose drives protein glycation, oxidative stress, and vascular inflammation, damaging blood vessels in the kidneys, retina, feet, coronary arteries, and carotid arteries.
"It triggers a process called glycation where glucose molecules literally stick to proteins in the vessel walls and change their structure making them stiff and dysfunctional. They don't work as well because glucose has changed them. It drives something called oxidative stress which is a kind of cellular rust and it also triggers chronic inflammation inside the blood vessels themselves. So over years this really does damage the tiny blood vessels supplying the kidneys and the back of your eyes, the retina and it can cause blindness and neuropathy in your feet. And importantly, it also accelerates the stiffening of your coronary arteries feeding your heart and the carotid arteries feeding your brain." (said at 0:07:15)
The host's statement accurately describes established vascular pathophysiology in chronic hyperglycemia. Elevated blood glucose non-enzymatically glycates long-lived extracellular matrix proteins (such as collagen) to form advanced glycation end products (AGEs), directly cross-linking proteins to increase vascular stiffness. Interaction between AGEs and cellular receptors (RAGE) further triggers intracellular pathways that promote oxidative stress and chronic vascular inflammation. These mechanisms drive microvascular damage, leading to diabetic retinopathy, nephropathy, and neuropathy, as well as macrovascular arterial stiffening affecting coronary and carotid vessels.
- supports: Clinical review: The role of advanced glycation end products in progression and complicati… (The Journal of clinical endocrinology and metabolism 2008) · cited 994x in the literature
"First, AGEs act directly to induce cross-linking of long-lived proteins such as collagen to promote vascular stiffness, and, thus, alter vascular structure and function. Second, AGEs can interact with certain receptors, such as the receptor for AGE, to induce intracellular signaling that leads to enhanced oxidative stress and elaboration of key proinflammatory and prosclerotic cytokines." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Arterial stiffness in diabetes mellitus. (Atherosclerosis 2015) · cited 318x in the literature
"Using a systematic literature search strategy, we aimed to summarize our current understanding related to arterial stiffness in DM. We review key studies demonstrating that, among patients with established DM, arterial stiffness is closely related to the progression of complications of DM, including nephropathy, retinopathy, and neuropathy." (abstract, results, passage verified)
pubmedfull study (doi)
The human liver holds approximately 100 grams of glycogen and muscles hold between 400 and 500 grams, totaling roughly 2,000 calories of glycogen storage.
"Your liver holds around 100 g of glycogen. That's it. Your muscles hold between 4 and 500 grams between them, you know, depending on how big you are. So, in total, that is roughly 2,000 calories worth of glycogen storage, enough to get you through a day of normal activity or a couple of hours of really intense exercise." (said at 0:10:22)
Established physiological literature confirms that in healthy adult humans, hepatic glycogen storage capacity is approximately 100 grams, while skeletal muscle stores approximately 400 to 500 grams (varying with body mass and training status). Because carbohydrates yield approximately 4 kcal per gram, a total body glycogen pool of roughly 500 to 600 grams equates to about 2,000 to 2,400 kcal of stored energy.
Plant starch has branch points roughly every 25 to 30 glucose units, whereas animal glycogen branches roughly every 8 to 12 glucose units.
"starch which is the storage form in plants has a relatively simple branching structure with branch points occurring roughly every sort of 25 to 30 glucose units. Glycogen which is the storage form in animals including humans is far more densely branched with a new branch point roughly every 8 or 12 glucose units." (said at 0:20:05)
The host's statement accurately reflects established structural biochemistry. Plant starch (specifically amylopectin, its branched component) features sparse branching with alpha-1,6-glucosidic branch points occurring approximately every 24 to 30 glucose residues (~4-5% branch density). In contrast, animal glycogen is much more densely branched, with branch points occurring approximately every 8 to 12 glucose units (~8-10% branch density), facilitating rapid mobilization of glucose.
Fatty acid breakdown in the liver via beta-oxidation produces three ketone bodies: beta-hydroxybutyrate, acetoacetate, and acetone.
"the liver starts breaking down fatty acids in the liver through a process called beta oxidation. And as a byproduct it produces three types of ketone bodies. The first one is beta-hydroxybutyrate. Then you've got acetoacetate and then finally one called acetone." (said at 0:21:13)
The speaker accurately describes basic human biochemistry: when fatty acids undergo hepatic beta-oxidation, the generated acetyl-CoA is converted via ketogenesis into three ketone bodies: acetoacetate, beta-hydroxybutyrate, and acetone.
Ketones can supply approximately 70% to 75% of the brain's energy requirements, with the remaining 25% to 30% requiring glucose.
"Now ketones can fuel roughly 70 to 75% of the brain's energy needs. The remaining 25 to 30% still requires glucose." (said at 0:23:46)
Human metabolic catheterization studies demonstrate that during deep or prolonged ketosis (such as during prolonged starvation), ketone bodies (beta-hydroxybutyrate and acetoacetate) replace glucose as the primary cerebral fuel, supplying up to approximately two-thirds to three-quarters (roughly 60% to 75%) of total cerebral energy requirements. The remaining cerebral energy requirement (approximately 25% to 30%) continues to rely on glucose.
A standard ketogenic diet consists of 70% to 75% calories from fat, 20% from protein, and 5% to 10% (under 20 to 50 grams per day) from carbohydrates.
"a true keto diet means getting around 70 to 75% of your total calories from fat, around 20% from protein, and no more than 5 to 10% from carbohydrates. Because, let's be honest, it is pretty difficult to eliminate carbs entirely. Now, in practical gram terms, that usually means staying under 20 to 50 grams of carbs per day." (said at 0:27:53)
The speaker's definition aligns with the standard nutritional definition of a standard ketogenic diet (SKD). In clinical nutrition literature and reviews, a standard ketogenic diet is defined by a macronutrient distribution of approximately 70% to 75% (or >70%) of total daily energy from fat, roughly 20% from protein, and 5% to 10% from carbohydrates, corresponding to an absolute carbohydrate intake restricted to under 20 to 50 grams per day to induce and maintain physiological nutritional ketosis.
- supports: Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) … (European journal of clinical nutrition 2013) · cited 904x in the literature
"Very-low-carbohydrate diets or ketogenic diets have been in use since the 1920s as a therapy for epilepsy and can, in some cases, completely remove the need for medication. From the 1960s onwards they have become widely known as one of the most common methods for obesity treatment." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The Ketogenic Diet: Evidence for Optimism but High-Quality Research Needed. (The Journal of nutrition 2020) · cited 138x in the literature
"Recently, ketogenic diets have received substantial attention from the general public and nutrition research community. These very-low-carbohydrate diets, with fat comprising >70% of calories, have been dismissed as fads. However, they have a long history in clinical medicine and human evolution." (abstract, results, passage verified)
pubmedfull study (doi)
Depletion of glycogen stores to initiate ketone production requires approximately 12 to 24 hours of fasting or a shorter period of intense exercise.
"The third one, once those glycogen stores are depleted, which takes somewhere between 12 and 24 hours of fasting or much faster during intense exercise, the body shifts to burning fat and producing ketones." (said at 0:19:07)
Published literature on the physiological responses to fasting confirms that the 'metabolic switch'—the transition from glucose utilization to fatty acid mobilization and ketone production following liver glycogen depletion—typically occurs after 12 hours of fasting (ranging between 12 and 24 hours). Physical exercise accelerates glycogen depletion due to increased rate of carbohydrate oxidation.
During gluconeogenesis, the liver synthesizes glucose using amino acids and glycerol derived from fat molecules as substrates.
"Well, your liver makes it through a process called gluconeogenesis, which literally means making new glucose. The liver can manufacture glucose from amino acids, which are the building blocks of proteins, and from glycerol, which is a component of fat molecules." (said at 0:23:50)
The speaker's explanation of hepatic gluconeogenesis is an established biochemical fact. During periods of fasting or low carbohydrate availability, the liver synthesizes endogenous glucose using non-carbohydrate precursors, prominently including gluconeogenic amino acids (from protein breakdown) and glycerol (the backbone of triglyceride fat molecules released via lipolysis), along with lactate and pyruvate.
In Alzheimer's disease, the brain's capacity to metabolize and utilize glucose declines.
"Now some research suggests that ketones may produce slightly less oxidative stress during energy metabolism, a kind of cleaner burn if you like, which has driven a lot of interest in their potential protective role in diseases like Alzheimer's where the brain's ability to use glucose seems to decline." (said at 0:25:11)
The claim accurately reflects the established scientific consensus on cerebral energy metabolism in Alzheimer's disease (AD). Extensive neuroimaging and metabolic research demonstrates that brain glucose uptake and utilization are significantly reduced in AD (often referred to as cerebral glucose hypometabolism). Fluorodeoxyglucose positron emission tomography (18F-FDG PET) studies consistently show regional declines in cerebral glucose metabolism, which correlate with cognitive impairment and emerge early in the course of the disease.
- supports: Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's… (Frontiers in neuroscience 2023) · cited 35x in the literature
"As glucose utilization is compromised in the brain of patients with AD, ketone bodies (KBs) may serve as an alternative source of energy." (abstract, background, passage verified)
pubmedfull study (doi) - supports: Metabolic drivers of Alzheimer's disease pathogenesis: Impairments in glucose utilization,… (International review of neurobiology 2026)
"During AD pathogenesis, the loss of glucose transporters and the downregulation of key glycolytic enzymes deprives neurons of essential energy reserve." (abstract, passage verified)
pubmedfull study (doi) - supports: Cerebral Glucose Hypometabolism in Alzheimer's Disease: A Meta-Analysis and Transcriptomic… (Current Alzheimer research 2026)
"Cerebral glucose hypometabolism is known to occur in Alzheimer's Disease (AD)... Compared with healthy controls, AD patients showed significant glucose hypometabolism in regions including the bilateral precuneus, median cingulate/paracingulate gyri, posterior cingulate gyri, angular gyri, inferior parietal gyri, supramarginal gyri, middle occipital gyri, middle temporal gyri, inferior temporal gyri, the left inferior frontal gyrus (triangular part), and anterior cingulate/ paracingulate gyrus." (abstract, background and results)
pubmedfull study (doi)
Consumption of legumes such as lentils, chickpeas, and beans has been consistently linked in large studies to reduced cardiovascular risk and reduced all-cause mortality.
"They've been consistently linked in large studies to reduced cardiovascular risk and reduced all-cause mortality, death from any cause." (said at 0:30:02)
Large prospective cohort studies and comprehensive systematic reviews and meta-analyses have consistently demonstrated that higher legume intake is associated with modest reductions in both all-cause mortality and cardiovascular disease (CVD) incidence. A 2023 dose-response meta-analysis of 32 cohorts encompassing over 1.1 million participants found a statistically significant 6% reduction in all-cause mortality comparing high versus low consumption (HR: 0.94; 95% CI: 0.91-0.98). Similarly, meta-analyses of prospective cohorts evaluating cardiovascular disease endpoints report significant risk reductions of 6% to 8% for total CVD incidence and 10% for coronary heart disease.
- supports: Associations between Dietary Pulses Alone or with Other Legumes and Cardiometabolic Diseas… (Advances in nutrition (Bethesda, Md.) 2019) · cited 128x in the literature
"Comparing the highest with the lowest level of intake, dietary pulses with or without other legumes were associated with significant decreases in CVD (RR: 0.92; 95% CI: 0.85, 0.99), CHD (RR: 0.90; 95% CI: 0.83, 0.99), hypertension (RR: 0.91; 95% CI: 0.86, 0.97), and obesity (RR: 0.87; 95% CI: 0.81, 0.94) incidence." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Intake of legumes and cardiovascular disease: A systematic review and dose-response meta-a… (Nutrition, metabolism, and cardiovascular diseases : NMCD 2023) · cited 61x in the literature
"When comparing extreme categories of intake, the consumption of legumes was inversely associated with CVD (n = 25: RR = 0.94; 95%CI:0.89,0.99) and CHD (n = 16: RR = 0.90; 95%CI:0.85,0.96), but not with stroke (n = 9: RR = 1.00; 95%CI:0.93,1.08)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Legume Consumption and Risk of All-Cause and Cause-Specific Mortality: A Systematic Review… (Advances in nutrition (Bethesda, Md.) 2023) · cited 44x in the literature
"Thirty-two cohorts (31 publications) involving 1,141,793 participants and 93,373 deaths from all causes were included. Higher intakes of legumes, compared with lower intakes, were associated with a reduced risk of mortality from all causes (HR: 0.94; 95% CI: 0.91, 0.98; n = 27) and stroke (HR: 0.91; 95% CI: 0.84, 0.99; n = 5)." (abstract, results, passage verified)
pubmedfull study (doi)
A 2024 randomized controlled trial from the University of Bath published in Cell Reports Medicine compared a control diet, a low-sugar diet, and a ketogenic diet over 12 weeks in 53 participants.
"So, a 2024 randomized controlled trial from the University of Bath published in Cell Reports Medicine compared three groups over 12 weeks: a control diet, a low-sugar diet, and a full ketogenic diet. Now, let's be upfront about the sample size here. So, it involved 53 people." (said at 0:32:36)
The speaker accurately describes the 2024 randomized controlled trial conducted by researchers at the University of Bath and published in Cell Reports Medicine. The trial (Hengist et al., 2024) evaluated 53 healthy participants randomized across three parallel arms—a moderate-carbohydrate control diet, a restricted free-sugar diet, and a ketogenic diet—over a 12-week intervention period.
In the 2024 University of Bath randomized controlled trial, the ketogenic diet group lost an average of 2.9 kg of fat and the low-sugar group lost approximately 2.1 kg of fat.
"The keto group lost an average of 2.9 kilos of fat, and the low-sugar group lost around 2.1 kilos." (said at 0:33:08)
The statement accurately reflects the findings of the 2024 randomized controlled trial conducted by researchers at the University of Bath (Hengist et al., published in Cell Reports Medicine). In this 12-week three-arm trial in healthy adults, fat mass decreased by an average of 2.9 kg in the ketogenic diet group and 2.1 kg in the free-sugar restriction group compared to the control diet, without altering energy expenditure.
In the 2024 University of Bath trial, the ketogenic diet group experienced a significant rise in LDL cholesterol and ApoB, whereas the low-sugar group had no change in ApoB.
"So the keto group saw a significant rise in something called LDL cholesterol and apolipoprotein B, known as ApoB... the Bath study, the study in this topic that we're talking about now, found that the keto group increased ApoB significantly. The low-sugar group in the middle had no change in ApoB at all." (said at 0:33:40)
A 2024 randomized controlled trial conducted at the University of Bath and published in Cell Reports Medicine evaluated the metabolic effects of a 12-week ketogenic diet versus a free-sugar restricted diet and a control diet in healthy adults. The trial found that the ketogenic diet led to a significant increase in apolipoprotein B (ApoB), along with changes in lipid metabolism, whereas restricting free sugars minimally affected systemic metabolic markers (with a decrease in LDL-C and no increase in ApoB).
There is exactly one apolipoprotein B molecule on the surface of each LDL particle.
"Apolipoprotein B is a protein that sits on the surface of each LDL particle, one per particle without any exception." (said at 0:34:44)
Biochemical, biophysical, and structural literature consistently demonstrates that apolipoprotein B (specifically ApoB-100 in humans) serves as the non-exchangeable structural scaffold of low-density lipoprotein (LDL) particles, with a strict 1:1 stoichiometry (one ApoB molecule per LDL particle). Because of this invariable one-to-one ratio, plasma ApoB concentration directly reflects total circulating atherogenic particle count.
Multiple major cardiology studies show that ApoB is a superior predictor of cardiovascular events compared to LDL cholesterol alone.
"Multiple major cardiology studies have shown that ApoB is a much better predictor of cardiovascular events than LDL cholesterol alone, which is why many lipidologists now consider it to be the gold standard measurement." (said at 0:35:15)
Multiple large prospective observational studies and meta-analyses demonstrate that apolipoprotein B (ApoB) is a stronger predictor of cardiovascular disease and vascular events than low-density lipoprotein cholesterol (LDL-C) alone. A major meta-analysis of 12 independent prospective epidemiological studies (233,455 subjects, 22,950 events) found that ApoB was the most potent marker of cardiovascular risk (relative risk ratio [RRR] 1.43, 95% CI 1.35–1.51) compared to LDL-C (RRR 1.25, 95% CI 1.18–1.33), with ApoB RRR being 12.0% higher than LDL-C (P < 0.0001) (PMID: 21487090). Similarly, large pooled analyses from the Emerging Risk Factors Collaboration demonstrated strong predictive performance for ApoB and ApoB ratios in cardiovascular risk estimation (PMID: 19903920).
- supports: Major lipids, apolipoproteins, and risk of vascular disease. (JAMA 2009) · cited 2789x in the literature
"For the subset with apolipoproteins or directly measured LDL-C, HRs were 1.50 (95% CI, 1.38-1.62) with the ratio non-HDL-C/HDL-C, 1.49 (95% CI, 1.39-1.60) with the ratio apo B/apo AI, 1.42 (95% CI, 1.06-1.91) with non-HDL-C, and 1.38 (95% CI, 1.09-1.73) with directly measured LDL-C." (abstract, results, passage verified)
pubmedfull study (doi) - supports: A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein chole… (Circulation. Cardiovascular quality and outcomes 2011) · cited 653x in the literature
"Whether analyzed individually or in head-to-head comparisons, apoB was the most potent marker of cardiovascular risk (RRR, 1.43; 95% CI, 1.35 to 1.51), LDL-C was the least (RRR, 1.25; 95% CI, 1.18 to 1.33), and non-HDL-C was intermediate (RRR, 1.34; 95% CI, 1.24 to 1.44). The overall comparisons of the within-study differences showed that apoB RRR was 5.7%>non-HDL-C (P<0.001) and 12.0%>LDL-C (P<0.0001)..." (abstract, results, passage verified)
pubmedfull study (doi)
A ketogenic diet raises HDL cholesterol and reduces blood triglycerides.
"keto also raises HDL cholesterol, the so-called good cholesterol, and it also reduces your triglycerides, which are fats in the blood." (said at 0:35:46)
Multiple comprehensive systematic reviews and meta-analyses of randomized controlled trials demonstrate that ketogenic diets significantly increase high-density lipoprotein cholesterol (HDL-C) and significantly decrease circulating triglyceride levels compared to control diets. For instance, a meta-analysis of 53 randomized trials found that ketogenic diets significantly reduced triglycerides (weighted mean difference: -22.31 mg/dL) and increased HDL-C (weighted mean difference: +3.52 mg/dL). These lipid changes are well-documented across adult populations, though meta-analyses also consistently observe concurrent elevations in LDL and total cholesterol.
- supports: The Impact of the Ketogenic Diet on the Lipid Profile in Adults: A Comprehensive Review an… (Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2026) · cited 3x in the literature
"The meta-analysis results from the included randomized controlled trials indicated a significant decrease in triglyceride levels (weighted mean difference [WMD]: -19.96 mg/dl, 95% CI: -26.10 to -13.81) and the triglyceride/high-density lipoprotein-cholesterol (HDL-C) ratio (WMD: -0.31, 95% CI: -0.49 to -0.12), despite a notable increase in HDL-C (WMD: 3.61 mg/dl, 95% CI: 1.44 to 5.57)..." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Ketogenic diet-induced changes in adult lipid metabolism: a comprehensive systematic revie… (BMC cardiovascular disorders 2026)
"Compared with control diets, KD significantly reduced triglycerides (WMD: -22.31 mg/dL; 95% CI: -28.90 to -15.72; p < 0.001; I2 = 69.8%, p < 0.001). HDL-C increased significantly (WMD: 3.52 mg/dL; 95% CI: 1.24 to 5.81; p < 0.001; I2 = 92.5%, p < 0.001)." (abstract, results, passage verified)
pubmedfull study (doi)
A 2023 umbrella review in BMC Medicine covering 17 meta-analyses and 68 RCTs found that the increase in LDL cholesterol from ketogenic diets was rated as high-quality evidence under GRADE.
"And a separate umbrella review of meta-analyses published in BMC Medicine in 2023 covered 17 meta-analyses and 68 randomized controlled trials and found that this increase in LDL cholesterol from keto was rated as high-quality evidence... Only four findings in that entire review reached the high-quality evidence status, and the LDL rise was one of them." (said at 0:39:21)
A 2023 umbrella review published in BMC Medicine evaluated 17 meta-analyses encompassing 68 randomized controlled trials assessing the health outcomes of ketogenic diets. Out of 115 evaluated associations, only four were supported by high-quality evidence according to GRADE criteria: reduced seizure frequency, two separate measures of reduced triglycerides, and increased low-density lipoprotein cholesterol (LDL-C).
A 2024 mouse study found that a continuous ketogenic diet drove cellular senescence in heart and kidney tissues through the p53 molecular pathway, while intermittent ketogenic feeding did not.
"So a study published in 2024 found that mice... on a long-term continuous ketogenic diet accumulated what are called senescent cells in multiple organs, particularly the heart and the kidneys... What this study found was that a continuous ketogenic diet appeared to drive senescence through a specific molecular pathway involving a protein which many of you might have heard of called p53... The critically important nuance here for this study is that mice on an intermittent ketogenic diet with planned breaks instead of a continuous one didn't show that same accumulation." (said at 0:41:28)
A 2024 study published in Science Advances investigated the effects of a ketogenic diet (KD) in mice. The authors found that continuous ketogenic feeding induced cellular senescence across multiple organs, specifically highlighting the heart and kidney, via an AMPK- and caspase-2-mediated pathway resulting in p53 accumulation and p21 activation. The study also demonstrated that this cellular senescence was prevented by an intermittent ketogenic feeding regimen. Because this evidence comes primarily from preclinical animal models and mechanistic assays, the certainty of evidence for human clinical translation remains very low.
The human gut contains approximately 38 trillion bacteria.
"Well, your gut contains approximately 38 trillion with a T bacteria. 38 trillion—more than you have human cells in your entire body." (said at 0:46:35)
A landmark quantitative analysis by Sender et al. (2016) calculated revised estimates for the number of human and bacterial cells in a standard 70-kg "reference man." They estimated that the human body harbors approximately 3.8 × 10¹³ (38 trillion) bacteria—the vast majority residing in the colon—compared to roughly 3.0 × 10¹³ (30 trillion) human cells.
Short-chain fatty acids produced by gut bacteria improve cellular insulin sensitivity.
"short-chain fatty acids produced by beneficial gut bacteria improve how your cells respond to insulin." (said at 0:48:39)
Short-chain fatty acids (SCFAs)—primarily acetate, propionate, and butyrate produced by the fermentation of dietary fibers by gut microbiota—improve insulin sensitivity and glucose homeostasis. A systematic review and meta-analysis of human clinical trials evaluating SCFA interventions demonstrated that confirmed increases in SCFA levels significantly reduce fasting insulin concentrations and improve the homeostatic model assessment of insulin resistance (HOMA-IR).
In the University of Bath trial, the ketogenic diet reduced dietary fiber intake to around 15 grams per day and caused a significant, sustained reduction in Bifidobacteria.
"Now, that Bath randomized controlled trial that I talked about earlier found that the ketogenic diet dropped fiber intake to around 15 grams per day, roughly half the NHS recommended intake of 30 grams per day, which still is a bit low to be honest. And the result was a significant and sustained reduction in something called Bifidobacteria, one of the most important families of beneficial gut bacteria." (said at 0:49:11)
The University of Bath randomized controlled trial (Hengist et al., 2024, published in Cell Reports Medicine) investigated the effects of a 12-week ketogenic diet compared to free-sugar restriction and a control diet in healthy adults. The trial confirmed that the ketogenic diet significantly altered the gut microbiome, alongside reductions in carbohydrate and fiber intake to approximately 15 g/day and marked depletion of key fiber-degrading bacteria including Bifidobacteria.
A 2025 systematic review analyzing 290 ketogenic diet trials from 2019 to 2024 found that 227 (78%) lasted less than 6 months.
"A systematic review published in 2025 analyzing 290 ketogenic diet trials between 2019 and 2024 found that 227 of those trials, so 227 out of 290, 78% lasted less than 6 months." (said at 0:51:16)
A 2025 systematic review of ketogenic diet research published between 2019 and August 2024 identified 290 trials across 32 topic areas. Among these, exactly 227 trials (78.3%) had an intervention or follow-up duration of less than six months, while 61 trials lasted more than six months.
In the Keto-Med crossover trial comparing a ketogenic diet to a Mediterranean diet over 24 weeks with a 12-week free-choice follow-up, participants consistently shifted toward the Mediterranean diet pattern during the free-choice period.
"Now the Keto-Med crossover trial which compared the ketogenic diet directly to the Mediterranean diet over 24 weeks followed by a 12-week free choice follow-up found something really interesting... when people were free to eat as they chose at that 36-week follow-up, dietary patterns had shifted consistently and clearly towards the Mediterranean pattern." (said at 0:51:47)
The Keto-Med randomized crossover trial (Gardner et al., 2022) directly compared a well-formulated ketogenic diet (WFKD) to a Mediterranean-plus diet (Med-Plus) over two 12-week intervention phases (24 weeks total), followed by a 12-week post-intervention follow-up period during which participants were free to choose their own dietary pattern. Analysis of the follow-up period demonstrated that participants were less able to maintain the ketogenic diet and shifted significantly toward the Mediterranean dietary pattern, indicating that the Mediterranean diet was more sustainable for participants long-term.
- supports: Adherence to Ketogenic and Mediterranean Study Diets in a Crossover Trial: The Keto-Med Ra… (Nutrients 2021) · cited 61x in the literature
"Diet was assessed at six time points including baseline (×1), week 4 of each phase when participants were receiving food deliveries (×2), week 12 of each phase when participants were preparing and providing food on their own (×2), and 12 weeks after participants completed both diet phases and were free to choose their own diet pattern (×1)." (abstract, methods, passage verified)
pubmedfull study (doi) - supports: Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals… (The American journal of clinical nutrition 2022) · cited 149x in the literature
"The WFKD led to a greater decrease in triglycerides, but also had potential untoward risks from elevated LDL cholesterol and lower nutrient intakes from avoiding legumes, fruits, and whole, intact grains, as well as being less sustainable." (abstract, conclusions, passage verified)
pubmedfull study (doi)
The UK NHS recommended dietary fiber intake for adults is 30 grams per day.
"the ketogenic diet dropped fiber intake to around 15 grams per day, roughly half the NHS recommended intake of 30 grams per day" (said at 0:49:11)
UK dietary guidelines adopted by the National Health Service (NHS), based on the UK Scientific Advisory Committee on Nutrition (SACN) recommendations, advise that adults should consume 30 grams of dietary fibre per day.
Human gut bacteria synthesize B vitamins and vitamin K.
"What we do know is that these bacteria produce vitamins, particularly B vitamins and vitamin K." (said at 0:47:06)
The claim accurately reflects human gastrointestinal physiology and gut microbiota capacity. Human gut commensal bacteria synthesize essential micronutrients, including B-group vitamins (such as folate, riboflavin, cobalamin, thiamine, and biotin) and vitamin K (specifically menaquinones).
A randomized controlled trial from the University of Bath showed that a ketogenic diet temporarily reduces glucose tolerance due to a muscular adaptation to low carbohydrate availability.
"And there is also a specific concern with this cycling approach that that Bath randomized controlled trial highlighted that keto reduces your glucose tolerance, meaning the body becomes temporarily less efficient at handling carbohydrates from a meal. And this appears to be a muscular adaptation to low carbohydrate availability." (said at 1:00:58)
A 2024 randomized controlled trial conducted at the University of Bath evaluated healthy adults following a ketogenic diet, a free-sugar restriction diet, or a control diet. The study demonstrated that the ketogenic diet decreased oral glucose tolerance and altered skeletal muscle phenotype by increasing pyruvate dehydrogenase kinase 4 (PDK4) and reducing glucose transporter 4 (GLUT4) and AMPK levels, reflecting a muscular adaptation to low carbohydrate availability.
Ultra-processed foods provide roughly two-thirds of the added sugar and refined carbohydrates in the average Western diet.
"If you remove ultra-processed foods from your diet, which provides roughly 2/3 of the added sugar and refined carbohydrates in the average western diet and you replace it with whole foods, you automatically cut your sugar intake." (said at 1:05:31)
Nationally representative dietary surveillance data from Western populations confirm that ultra-processed foods are the primary driver of added sugar and refined carbohydrate intake. In the US National Health and Nutrition Examination Survey (NHANES), ultra-processed foods account for approximately 58% to 65% of total daily caloric intake and contribute 89.7% to 92.0% of all added sugars in the diet. The speaker's estimate of 'roughly two-thirds' is accurate regarding total energy contribution from ultra-processed foods and slightly understates their actual contribution to added sugar intake.
A meta-analysis of 29 observational studies covering over 1.6 million people found that greater adherence to a Mediterranean diet was associated with a 10% reduction in all-cause mortality.
"Now, as an example of that, a meta-analysis of 29 observational studies covering over 1.6 million people found greater adherence to this kind of diet was associated with a 10% reduction in all-cause mortality, dying from any cause." (said at 1:09:08)
The host's statement accurately summarizes the findings of a 2019 systematic review and meta-analysis of prospective cohort studies. The meta-analysis analyzed 29 prospective cohort studies involving 1,676,901 participants and found that a 2-point increment in adherence to a Mediterranean diet was associated with a pooled hazard ratio of 0.90 for all-cause mortality (a 10% reduction in risk). Because these data derive from observational cohort studies, the overall certainty of evidence is low.
A 25-year cohort study of over 25,000 women found that those eating closest to a Mediterranean diet pattern had a 23% lower risk of all-cause mortality during the study period, alongside improvements in inflammatory markers, insulin resistance, blood pressure, and weight.
"Another study, a 25-year cohort study of over 25,000 women, one of the longest dietary follow-up studies ever conducted, found that those eating closest to this pattern, had a 23% lower risk of dying during that study time with improvements in inflammatory markers and insulin resistance, um, blood pressure and weight as well." (said at 1:09:26)
A prospective cohort study of 25,315 female participants from the Women's Health Study followed for an average of 24.7 years found that high adherence to a Mediterranean diet (score 6–9 vs. 0–3) was associated with a 23% reduction in all-cause mortality risk (HR 0.77, 95% CI 0.70–0.84 in initial multivariable models). Mediation analyses showed that the mortality benefit was partially explained by improvements in cardiometabolic pathways, including inflammatory biomarkers (explaining 13.0% of the association), body mass index (10.2%), insulin resistance (7.4%), and blood pressure/hypertension (<3%).
- supports: Mediterranean Diet Adherence and Risk of All-Cause Mortality in Women. (JAMA network open 2024) · cited 41x in the literature
"Among 25 315 participants, the mean (SD) baseline age was 54.6 (7.1) years... Over a mean (SD) of 24.7 (4.8) years of follow-up, 3879 deaths occurred. Compared with low Mediterranean diet adherence (score 0-3), adjusted risk reductions were observed for middle (score 4-5) and upper (score 6-9) groups, with HRs of 0.84 (95% CI, 0.78-0.90) and 0.77 (95% CI, 0.70-0.84), respectively (P for trend < .001)... Of the biomarkers examined, small molecule metabolites and inflammatory biomarkers contributed most to the lower mortality risk (explaining 14.8% and 13.0%, respectively, of the association), followed by triglyceride-rich lipoproteins (10.2%), body mass index (10.2%), and insulin resistance (7.4%). Other pathways, including branched-chain amino acids, high-density lipoproteins, low-density lipoproteins, glycemic measures, and hypertension, had smaller contributions (<3%). In this cohort study, higher adherence to the Mediterranean diet was associated with 23% lower risk of all-cause mortality." (abstract, results and conclusions)
pubmedfull study (doi)
A systematic review covering over 158,000 older adults found that high adherence to a Mediterranean-style dietary pattern reduced all-cause mortality by 23% and cardiovascular mortality by 27%.
"And then another study for you, a systematic review covering over 158,000 older adults found that high adherence to this sort of dietary pattern reduced all-cause mortality by 23% and cardiovascular mortality by 27%." (said at 1:09:53)
A 2024 systematic review and meta-analysis of 28 studies (26 observational cohorts and 2 randomized trials) in older adults (mean age > 60 years) found that high adherence to a Mediterranean diet was associated with a 23% reduction in all-cause mortality (RR 0.77, 95% CI: 0.70-0.83) and a 27% reduction in cardiovascular mortality (RR 0.73, 95% CI: 0.64-0.84).
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.